Alicanto®
A better way to discover antibodies.
Alicanto® is Digital Proteomics’ novel antibody discovery platform that identifies target-specific antibodies from serum. Our unique technology selects high affinity antibodies without requiring time-consuming and inefficient cell selection, fusions, or cloning. Alicanto® can be applied to discover monoclonal antibodies from rabbits, llamas, goats, and humans.
Jump to:
– Single domain antibody discovery
– Rabbit monoclonal antibody discovery
– Human monoclonal antibody discovery